Net Cash Provided by (Used in) Operating Activities |
-4.29K |
USD |
+63.8% |
Q1 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Financing Activities |
-7.12K |
USD |
-179% |
Q1 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
105M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Common Stock, Shares, Issued |
13.6M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
127 |
USD |
-99.9% |
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Valuation Allowance |
9.09M |
USD |
+7.99% |
Q3 2022 |
Q3 2022 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-11.4K |
USD |
-305% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
9.09M |
USD |
+7.99% |
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Issued |
2K |
shares |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Authorized |
2K |
shares |
|
Q3 2022 |
Q3 2022 |
Additional Paid in Capital |
8.45M |
USD |
+1.74% |
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Outstanding |
2K |
shares |
|
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2022 |
Q3 2022 |
Interest Expense |
28.7K |
USD |
+9461% |
Q1 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2022 |
Q3 2022 |